Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report
单位:[1]Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.临床科室神经内科神经内科首都医科大学附属北京友谊医院[2]Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background Neurocysticercosis (NCC) is the most common helminthic infection of the central nervous system (CNS) caused by the larval stage of Taenia solium. Accurate and early diagnosis of NCC remains challenging due to its heterogeneous clinical manifestations, neuroimaging deficits, variable sensitivity, and specificity of serological tests. Next-generation sequencing (NGS)-based pathogen analysis in patient's cerebrospinal fluid (CSF) with NCC infection has recently been reported indicating its diagnostic efficacy. In this case study, we report the diagnosis of a NCC patient with a symptomatic history of over 20 years using NGS analysis and further confirmation of the pathology by immunological tests. Case presentation This study reports the clinical imaging and immunological features of a patient with a recurrent headache for more than 20 years, which worsened gradually with the symptom of fever for more than 7 years and paroxysmal amaurosis for more than 1 year. By utilizing NGS technique, the pathogen was detected in patient's CSF, and the presence of Taenia solium-DNA was confirmed by a positive immunological reaction to cysticercus IgG antibody in CSF and serum samples. The symptoms of the patient were alleviated, and the CSF condition was improved substantially after the anti-helminthic treatment. Conclusions This study suggests that combining CSF NGS with cysticercus IgG testing may be a highly promising approach for diagnosing the challenging cases of NCC. Further studies are needed to evaluate the parasitic DNA load in patients' CSF for the diagnosis of disease severity, stage, and monitoring of therapeutic responses.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801334]
第一作者单位:[1]Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
通讯作者:
推荐引用方式(GB/T 7714):
Bin Chen,Zheng Chen,Yi-shu Yang,et al.Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report[J].BMC NEUROLOGY.2021,21(1):doi:10.1186/s12883-021-02277-7.
APA:
Bin Chen,Zheng Chen,Yi-shu Yang,Gui-lan Cai,Xiao-jiao Xu...&Hou-zhen Tuo.(2021).Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report.BMC NEUROLOGY,21,(1)
MLA:
Bin Chen,et al."Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report".BMC NEUROLOGY 21..1(2021)